Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3298963013 | Oral form pyrazinamide (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3299523012 | Oral form pyrazinamide | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3488643016 | Product containing pyrazinamide in oral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3497774014 | Pyrazinamide in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3497775010 | Product containing pyrazinamide in oral dosage form | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3711659014 | Pyrazinamide-containing product in oral dose form | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3711660016 | Product containing pyrazinamide in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing pyrazinamide in oral dose form (medicinal product form) | Is a | Product containing pyrazinamide | true | Inferred relationship | Existential restriction modifier | ||
| Product containing pyrazinamide in oral dose form (medicinal product form) | Is a | Product manufactured as oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing pyrazinamide in oral dose form (medicinal product form) | Has active ingredient | Pyrazinamide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing pyrazinamide in oral dose form (medicinal product form) | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing pyrazinamide in oral dose form (medicinal product form) | Plays role | Antitubercular therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely pyrazinamide 500 milligram/1 each conventional release oral tablet | Is a | False | Product containing pyrazinamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing isoniazid and pyrazinamide and rifampicin in oral dose form (medicinal product form) | Is a | True | Product containing pyrazinamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier | |
| Product containing only pyrazinamide in oral dose form (medicinal product form) | Is a | True | Product containing pyrazinamide in oral dose form (medicinal product form) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR